Antonio Strafella | University of Toronto, Toronto, ON, Canada
Thilo Van Eimeren | University of Cologne, Germany
Abstract
Differential diagnoses between Parkinsonian syndromes pose significant challenges for clinicians as clinical manifestations can overlap and there are no gold standard biomarkers. Multimodal translational approaches from novel molecular makers using positron emission tomography (PET) to the brain connectomics by means of magnetic resonance imaging (MRI) could help to elucidate the underlying brain mechanisms of parkinsonisms and their clinical prognoses.